Kevzara is a medicine for rheumatoid arthritis, polymyalgia rheumatica and some kinds of juvenile arthritis. It is given as a shot under the skin, usually every two weeks. It works by blocking IL-6, a signal in the body that drives joint pain, stiffness and swelling.
Every report comes from a Lived member, sent anonymously.
Have you tried Kevzara (Sarilumab) for Rheumatoid Arthritis?
Sarilumab, sold as Kevzara, is a prescription injection that calms the inflammation behind certain kinds of arthritis. In adults, it treats moderately to severely active rheumatoid arthritis (RA) when at least one disease-modifying antirheumatic drug, or DMARD, such as methotrexate, has not worked well enough or has caused side effects. DMARDs are medicines that slow the immune system's attack on the joints rather than only easing pain. It is also approved for adults with polymyalgia rheumatica (PMR), an inflammatory condition that causes pain and stiffness around the shoulders and hips, when steroids have not controlled it or symptoms come back each time the steroid dose is lowered. A third use is active polyarticular juvenile idiopathic arthritis (pJIA), a form of arthritis that begins in childhood and affects many joints, in young people who weigh at least 63 kg (about 139 pounds). It is not approved for lighter children because there is no suitable dose form for them.
Interleukin-6 (IL-6) is a signaling protein the immune system uses to switch on inflammation. In rheumatoid arthritis, cells inside the affected joints produce it, and throughout the body it prompts the liver to release inflammation markers such as C-reactive protein (CRP), a common blood test of inflammation. Sarilumab is a monoclonal antibody, a lab-made protein designed to lock onto one specific target. It attaches to the receptor that IL-6 acts through, so the signal cannot get through. Blocking this one pathway reduces joint swelling and stiffness, and in PMR it makes it easier to cut back on steroids. It does not cure either condition. The same blockade also explains several of its effects: IL-6 helps the body respond to infection and influences white blood cells, liver enzymes and blood fats, which is why those are watched during treatment.
For all three approved uses, the usual dose is 200 mg once every two weeks, injected under the skin with a single-use pre-filled pen or syringe. After training, people can inject it themselves at home or have a caregiver do it. In RA, it can be used on its own or together with methotrexate or another conventional DMARD. In PMR, it is started alongside a tapering course of a steroid such as prednisone and can continue on its own once the steroid has been stopped. Young people with pJIA use the 200 mg syringe; the pen is not intended for children. A lower 150 mg strength exists because, in RA, the prescriber may pause treatment and restart at the lower dose if blood tests show low neutrophils (infection-fighting white blood cells), low platelets or raised liver enzymes. In PMR, those same changes generally mean stopping the medicine rather than lowering the dose. Store Kevzara in the refrigerator in its carton, and do not freeze or shake it. Let a syringe sit at room temperature for 30 minutes, or a pen for 60 minutes, before injecting, and do not warm it any other way. Once out of the refrigerator, it can be kept at room temperature (no higher than 77°F) for up to 14 days. Rotate injection spots and avoid skin that is tender, bruised or scarred.
In RA trials, the most common effects were redness where the shot was given, colds and other upper respiratory infections, urinary tract infections, and two blood test changes: a lower neutrophil count and a rise in ALT, a liver enzyme that signals stress on liver cells. Itching at the injection site was common in PMR. The blood changes usually cause no symptoms, which is why routine testing matters. Cholesterol and triglycerides can also rise. Because sarilumab dampens part of the immune response, infections can become serious, and the medicine can also blunt the fever and other signs that normally reveal one. Contact the care team right away for fever, chills, a cough that will not go away, burning when urinating, red or painful skin, or feeling unusually unwell. Shingles has also occurred. Severe stomach pain that does not go away also needs a prompt call to the care team: rarely, tears in the stomach or intestine have happened, mostly as a complication of diverticulitis (inflamed pouches in the wall of the colon). Call 911 for signs of a serious allergic reaction, such as trouble breathing or swelling of the face, lips or tongue.
Kevzara carries the FDA's most serious type of warning, a boxed warning, for serious infections that can lead to hospitalization or death. These include tuberculosis (TB), invasive fungal infections and other opportunistic infections, which rarely affect people with a normal immune system. Most people who developed them were also taking methotrexate or steroids. Before starting, you will be tested for TB, and latent (inactive) TB is treated first; testing may be repeated during treatment. Sarilumab is not started during an active infection and is paused if a serious one develops. Frequent infections, past TB exposure, or living in or traveling to places where TB or certain fungal infections are common are worth raising beforehand. It should not be combined with other biologic arthritis medicines, such as TNF blockers (which block a different inflammation signal, tumor necrosis factor), because the immune suppression adds up. Avoid live vaccines during treatment, and ideally bring vaccinations up to date before starting. NSAIDs (anti-inflammatory pain relievers such as ibuprofen) and steroids add to the risk of a stomach or bowel tear. As with other medicines that suppress the immune system, a possible effect on cancer risk is not known; cancers were reported in trials. Sarilumab also changes how the liver processes some medicines. Ongoing inflammation slows certain liver enzymes, and blocking IL-6 can bring them back up to speed. Starting or stopping sarilumab can therefore shift the effect of drugs whose dose is finely adjusted, such as the blood thinner warfarin or the asthma medicine theophylline, and may make birth control pills or some cholesterol-lowering statins, such as atorvastatin, less effective. This effect can last several weeks after the last dose. It is not recommended for people with active liver disease. Human data in pregnancy are limited. Antibodies like sarilumab cross the placenta in the third trimester and may affect the baby's immune response, so a baby exposed before birth may need a different plan for live vaccines. Whether it passes into breast milk is unknown. Anyone pregnant, planning pregnancy or breastfeeding should weigh these points with the prescriber.
Blood markers of inflammation such as CRP usually fall to normal within about two weeks, but that reflects the drug's effect on the liver more than how the joints feel. In the main RA trials, about two in three people taking 200 mg with methotrexate had a meaningful improvement in joint symptoms by week 12, compared with about one in three taking placebo with methotrexate. Not everyone responds, and other medicines remain options if it falls short. In the PMR trial, 28% of people on sarilumab with a 14-week prednisone taper stayed in remission for a full year, compared with 10% on placebo with a slower, year-long taper, and twice as many managed to stick to their taper. Monitoring is part of the routine. Blood counts and liver tests are checked before the first dose, again 4 to 8 weeks later and then every 3 months. Cholesterol and triglycerides are checked 4 to 8 weeks in and then about every 6 months. Because the timing of neutrophil changes follows the dosing cycle, the care team may ask for blood to be drawn just before a dose is due. Treatment usually continues for as long as it controls the disease and side effects are manageable, and any decision to pause or stop is made with the rheumatologist.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Kevzara (Sarilumab), what you've noticed, or ask the community a question.